Pancreatic Cancer Research

ResearcherNanjing General Hospital of Nanjing Military CommandActive in the last 2 years

Xin Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-3668-4830; OpenAlex author ID A5100363126. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
21
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 3 papers · 2022: none · 2023: 1 paper · 2024: 3 papers

Papers 8

  1. Causal associations of tea consumption on risk of pancreatic adenocarcinoma and the mediating role of vascular endothelial growth factor D levels. Co-author DOI 10.1017/s0007114524002393↗
  2. Causal associations of tea consumption on risk of pancreatic adenocarcinoma and the mediating role of vascular endothelial growth factor D levels - CORRIGENDUM. Co-author DOI 10.1017/s0007114524003155↗
  3. Combining single-cell and bulk RNA sequencing, NK cell marker genes reveal a prognostic and immune status in pancreatic ductal adenocarcinoma. Last author DOI 10.1038/s41598-024-65917-1↗
  4. Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic cancer. Co-author DOI 10.1126/scitranslmed.adg3049↗
  5. Targeting ferroptosis in pancreatic cancer: a double-edged sword. Co-author DOI 10.1016/j.trecan.2021.04.005↗
  6. Cell death in pancreatic cancer: from pathogenesis to therapy. Co-author DOI 10.1038/s41575-021-00486-6↗
  7. Regulation and function of autophagy in pancreatic cancer. First author DOI 10.1080/15548627.2020.1847462↗
  8. High glucose microenvironment accelerates tumor growth via SREBP1-autophagy axis in pancreatic cancer. Co-author DOI 10.1186/s13046-019-1288-7↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yonghao Ouyang · 3 shared papers, 2024 · strength 0.73
  2. Rui Kang · 4 shared papers, 2021–2023 · strength 0.70
  3. Daolin Tang · 4 shared papers, 2021–2023 · strength 0.70
  4. Herbert J. Zeh · 2 shared papers, 2021 · strength 0.33
  5. Jiajia Lei · 1 shared paper, 2024 · strength 0.26
  6. Jiajia Lei · 1 shared paper, 2024 · strength 0.26
  7. Rongxi Shen · 1 shared paper, 2024 · strength 0.22
  8. Jingbo Li · 1 shared paper, 2023 · strength 0.18
  9. Brent R. Stockwell · 1 shared paper, 2023 · strength 0.18
  10. Jiao Liu · 1 shared paper, 2023 · strength 0.18
  11. Jingbo Li · 1 shared paper, 2021 · strength 0.16
  12. Qingyong Ma · 1 shared paper, 2019 · strength 0.09
  13. Zheng Wu · 1 shared paper, 2019 · strength 0.09
  14. Liang Cheng · 1 shared paper, 2019 · strength 0.09
  15. Weikun Qian · 1 shared paper, 2019 · strength 0.09
  16. Zhengdong Jiang · 1 shared paper, 2019 · strength 0.09
  17. Cancan Zhou · 1 shared paper, 2019 · strength 0.09
  18. Jiguang Ma · 1 shared paper, 2019 · strength 0.09
  19. Wanxing Duan · 1 shared paper, 2019 · strength 0.09
  20. Xuqi Li · 1 shared paper, 2019 · strength 0.09
  21. Zheng Wang · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.